{
  "retracted": false,
  "timestamp": 1533081600000,
  "updates": [
    {
      "timestamp": 1586818497179,
      "identifier": {
        "doi": "10.1016/j.steroids.2018.06.001"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.steroids.2017.11.009"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth” [Steroids 129 (2018) 24-34]"
}
